We have cloned regions of the 100-kilobase (kb) plasmid, pStSR100, of Salmonella typhimurium SR-11 that confer virulence to plasmid-cured S. typhimurium. Cells carrying recombinant plasmids that conferred virulence were selected by inoculating mice orally with recombinant libraries in virulence plasmid-cured S.
decreased virulence to degrees similar to those observed when the TnS insertions were present in pYA403. vir-22::TnS in pStSR100 greatly lowered infection of spleens relative to unmutagenized virulence plasmid, while vir-26::TnS and vir-27::TnS lowered splenic infection to lesser degrees. At least three proteins were encoded by pYA403 containing 23 kb of insert sequence and subclone pYA420, containing the 14-kb common insert sequence present in all of the cosmid clones. One of these proteins, with an apparent molecular weight of 28,000, was also encoded by pYA422. The TnS insertion that most attenuated virulence, vir-22::TnS, inhibited synthesis of the 28,000-molecular-weight protein. The vir-22::TnS insertion was complemented by recombinant plasmids encoding only the 28,000-molecular-weight protein, suggesting a role of this protein in virulence. However, recombinant plasmids, exemplified by pYA422, that encoded only the 28,000-molecular-weight protein did not confer full virulence.
The importance of large plasmids for the virulence of Salmonella typhimurium and other serotypes of Salmonella has been the subject of much research in recent years (1, 4, 14, 16, 18, 20, 24, (27) (28) (29) 32) . Although the exact contribution of the virulence plasmids to pathogenesis is still a matter of debate (14, 16, 18, 20, 24) , progress has been made in identifying regions of the plasmid necessary for conferring virulence. Popoff et al. (29) and Helmuth et al. (20) identified, by Southern blot hybridization, restriction digest bands that were shared among various serotypes. Baird et al. (1) identified regions of the S. typhimurium and Salmonella dublin virulence plasmids that had very similar restriction enzyme maps. They also constructed transposon insertion mutations that inhibited virulence to various degrees. Hackett and Wyk (17) cloned a gene encoding a 23,000-molecularweight membrane protein (23K protein), but they did not report any role for this gene in virulence. Hackett et al. (18) also cloned a gene from the S. typhimurium virulence plasmid that encoded an 11K protein which conferred serum resistance both to their virulence plasmid-cured S. typhimurium LT2 and to Escherichia coli K-12. Michiels et al. (27) identified a virulence-associated region of the S. typhimurium plasmid by deletion analysis. Most recently, Beninger et al. (4) further defined the virulence region of the S. dublin plasmid by transposon and deletion mutation analyses.
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Haven, Conn., according to the suppliers' instructions. Nick translation was done with a kit from Bethesda Research Laboratories according to the supplier's instructions with [a-32P]dATP (specific activity, 500 mCi/mmol; Amersham Corp., Arlington Heights, Ill.). Transformation was done by the procedure of Humphreys et al. (21) , and plasmid DNA extraction was done by the method of Birnboim (6) .
Construction of pStSR100 library in pCVD305. was confirmed by colony blot hybridization with 32P-labeled pStSR100.
The library was moved into virulence plasmid-cured S.
typhimurium SR-11 (strain X3337) by extraction of plasmid DNA of individual isolates of x3385 and transformation. Construction of pStSR100 library in pACYC184. pStSR100 DNA was partially digested with Sau3A, and fragments of less than 5 kb were isolated by centrifugation through a 5 to 30% (wt/vol) sucrose gradient. Sau3A-cut pStSR100 and BamHI-cut, calf alkaline phosphatase-treated (Boehringer Mannheim Biochemicals, Indianapolis, Ind.) pACYC184 (7) were ligated at 12°C for 16 h. Ligated DNA was transformed into S. typhimurium X3477, extracted from X3477, purified by cesium chloride density gradient centrifugation, and transformed into strain X3337.
Infection of mice. The procedures for infection of mice were based on results of our previous work on pathogenesis mediated by the virulence plasmid (14) . BALB/c mice ( 6 to 11 weeks old; Harlan Sprague-Dawley, Indianapolis, Ind.; Sasco Inc., St. Louis, Mo.) were inoculated p.o. after food and water deprivation and feeding of sodium bicarbonate as described before (14) . Spleens of infected mice were sampled at various times postinoculation and homogenized in 2.5 ml of buffered saline containing 0.1% (wt/vol) gelatin (BSG) (10) in glass tissue homogenizers. Alternatively, spleens were homogenized in 3 ml of BSG with a Brinkman tissue homogenizer (Brinkman Instruments, Inc., Westbury, N.Y.; model PT10/35). Samples were diluted and plated on L-agar plates containing appropriate antibiotics, and values are reported as total CFU per spleen. Most splenic infections were determined at 1 week postinoculation because this time point yielded the greatest difference in plasmid-mediated infection of spleens and preceded the death of mice infected with fully virulent Salmonella strains (14 E. coli minicells. The E. coli minicell-producing strain X925 was used to identify plasmid-encoded proteins as described before (8, 11, 12) . x925 carrying each plasmid was grown to stationary phase in minicell labeling medium (minimal saltsglucose medium [10] containing all amino acids except methionine and containing thiamine hydrochloride), diluted 10-4 in minicell labeling medium, and grown overnight with vigorous aeration. The following day, whole cells were removed by centrifugation at 2,000 x g for 10 min at room temperature, and minicells were harvested from the resulting supernatant fluid by centrifugation at 12,000 x g for 10 min. Minicells were suspended in BSG and centrifuged through a 5 to 30% (wt/vol) sucrose gradient in BSG at 3,000 x g for 15 min at room temperature in an SW-27 rotor (Beckman Instruments, Inc., Fullerton, Calif.). The upper band containing minicells was removed and slowly diluted with BSG, and minicells were pelleted by centrifugation at 12,000 x g for 10 min. The minicell pellet was suspended in 1 ml of minicell labeling medium and incubated at 37°C for 10 min, and plasmid-encoded proteins were intrinsically radiolabeled by addition of 10 to 25 jiCi of [35S]methionine (Amersham; specific activity, 1,500 ,uCi/mmol). After incubation at 37°C for 10 min, labeling was stopped by incubation on ice, followed by pelleting of minicells and solubilization of proteins in sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) sample buffer (19) . Radiolabeled proteins were resolved by SDS-PAGE in 10% (wt/vol) polyacrylamide gels (19) For analysis of results from mixed infections of mice with two different S. typhimurium strains, the geometric mean (log1o) of the ratios of CFU of the first strain to CFU of the second strain was examined for the difference from the ratio being 1 by using the one-tailed Student t test.
RESULTS
Construction of pStSR100 library in pCVD305 and selection of virulence-conferring clones in mice. The virulence plasmid of S. typhimurium SR-1l, pStSR100, was cloned into the cosmid vector pCVD305 by ligating 25-kb Sau3A fragments of pStSR100 into BamHI-cut pCVD305. A library consisting of 44 pStSR100-hybridization-positive recombinant clones in X2819 was successfully transferred into X3337. This number of clones possessing 25 kb of insert DNA was greater than the 31 clones necessary for a 99% probability of constructing a representative library of the 100-kb virulence plasmid (9) . Furthermore, digestion of the combined recombinant plasmid DNA present in the X3337 library with PvuII, EcoRI, and HindIll revealed that all bands of 10 kb or less from pStSR100 were present in the library (data not shown).
We (14) and others (16, 28) have determined that the virulence plasmid of S. typhimurium is essential for systemic infection from Peyer's patches to spleens. Recombinant plasmids that conferred the ability to infect spleens on pStSR100-cured S. typhimurium X3337 were selected by infecting mice p.o. and isolating bacteria from spleens. Six or eight BALB/c mice were inoculated p.o. with 107 or 109 CFU, respectively, of X3337 carrying the pStSR100 library.
To ensure that approximately equal numbers of CFU of each construct were inoculated, the 44 isolates were grown together on a single L-agar plate and harvested by suspension in BSG for infection of mice. In addition to examining the plasmid DNA content of cultures of infected spleen homogenates, individual colonies were obtained from each spleen homogenate culture and the plasmid content of these individual isolates was examined by restriction enzyme digestion. The DNA from three plasmids, pYA401, pYA402, and pYA403, obtained from the spleen of a single mouse harvested at 5 days after inoculation with 109 CFU, had all of the restriction enzyme digestion fragments of plasmid DNA from the spleen homogenate cultures from all of the mice infected with the pStSR100 library (data not shown). This was examined by using EcoRI, HindIII, PstI, and PvuII, which each yielded three to eight bands after restriction of the plasmid DNA of cultures of infected spleen homogenates.
Restriction endonuclease maps of pYA401, pYA402, and pYA403. Plasmids pYA401, pYA402, and pYA403 were extracted from X3337 and restricted with EcoRI and HindIII, and the resulting fragments were compared with those of pStSR100 generated by HindIIl and EcoRI digestion. The three recombinant plasmids were further mapped with the restriction enzymes BamHI, BglII, XhoI, and SalI ( a common 14-kb insert sequence representing 14% of the virulence plasmid pStSR100 (Fig. 1) . The 14-kb common insert sequence present in pYA403 was subcloned into pACYC184 by cutting pYA403 with Sall and BgiII and ligating into pACYC184 cut with Sall and BamHI. The subclone was designated pYA420 (Fig. 1 (Table 3 , part A). Twenty-two-fold more X3337(pYA422) than X3337(pACYC184) cells were recovered from spleens of infected mice (P < 0.025). However, 260-fold more wildtype x3456 than X3337(pYA422) cells were recovered from mice infected with both of these strains (P < 0.0025). Thus, pYA422 conferred virulence plasmid-cured S. typhimurium with increased but not wild-type levels of virulence, as measured by infection of spleens after p.o. inoculation.
Physical mapping of pYA403 and pYA422. The plasmids pACYC184 and pYA422 were digested with BamHI or the combination of BamHI and EcoRI and examined by agarose gel electrophoresis. After restriction with BamHI, pYA422 generated a 4.0-kb fragment which comigrated with pACYC184 and a 3.2-kb fragment which comigrated with BamHI fragment C of pStSR100, indicating that the Sau3A sites defining the insert sequence of pYA422 were present in the BamHI sites which define BamHI fragment C of pStSR100 (Fig. 1) . The cloned insert sequence of pYA422 also yielded two BamHI-EcoRI fragments that comigrated with EcoRI-generated fragments from BamHI fragment C. That the insert of pYA422 consisted of BamHI fragment C was confirmed by Southern blot analysis with 32P-labeled pYA422 with pStSR100, pYA401, pYA402, and pYA403 (data not shown). Thus, pYA422 carried the 3.2-kb BamHI fragment C of pStSR100 DNA, which was also present on the three cosmid clones which conferred the ability for splenic infection on plasmid-cured S. typhimurium.
Transposon insertion mutagenesis of pYA403, pYA422, and pStSR100. The cloned DNA sequences of pStSR100 present in pYA403 and pYA422 were subjected to transposon insertion mutagenesis. Three different TnS insertions in BamHI fragment C of pYA403 were analyzed for virulence (Fig. 1) yielded the highest ratio of wild-type to TnS mutant spleen isolates (2.5 x 103; P < 0.0025), while X3306(pStSR100 vir-26::TnS) and X3306(pStSR100 vir-27::TnS) yielded lower ratios (32 and 8.3, respectively; P > 0.05). The different levels of attenuation mediated by the three TnS insertions were not due to plasmid stability or instability, as all three TnS-mutated virulence plasmids were 100% stable after growth of bacteria in vitro for 20 generations and in vivo in mice for 4 days.
Identification of recombinant plasmid-encoded proteins. We used E. coli minicells to identify proteins expressed by virulence plasmid genes cloned into pCVD305 (Fig. 2) (Fig. 2, lane B) . pYA403 containing vir-22::TnS, which mapped to the left end of BamHI fragment C, no longer expressed the 28K protein in minicells (Fig. 2, lane C (Fig. 2, lane D) . The presence of the 29K aminoglycoside 3'-phosphotransferase II protein (calculated molecular weight) (3) was noted in minicells of TnS-containing plasmids (Fig. 2, lanes C and D, arrow) . In in vitro transcriptiontranslation of pACYC184 constructs, pYA422 expressed only the 28K protein (Fig. 3, lane B) . Of four TnS insertion mutations in pYA422, only vir-3::TnS, which mapped to the extreme left of BamHI fragment C, inhibited expression of the 28K protein (Fig. 3, lanes C to F) . pYA420, -which contains the 14-kb common sequence subcloned into pACYC184, expressed the same three proteins as pYA403 (Fig. 4, lanes A and B) . An additional 31K protein (apparent molecular weight) was also produced by pYA420. This protein may be a truncated product of a higher-molecularweight protein encoded in this region of the virulence plasmid but not identified by using pYA403 due to the inefficiency of pCVD305 constructs in minicells. The combined results of analysis of pYA422 and Tn5 insertions indicated that the 28K protein was encoded at the extreme left region of BamHI fragment C.
Complementation of vir-22::Tn5. The vir-22::TnS insertion mutation was originally examined for effects on virulence because it was located within the 3.2-kb BamHI fragment C of pStSR100 which had been cloned in virulence-conferring pYA422. We therefore investigated the ability of pYA422 to complement in trans the vir-22: :TnS insertion in pStSR100 of x3589. pYA422 was unable to restore the ability to infect spleens inhibited by the vir-22: :Tn5 mutation (data not shown).
To isolate recombinant plasmids capable of complementing the vir-22::TnS insertion, x3589 was transformed with the same recombinant library used to isolate pYA422 (see above). Three mice were infected p.o. with 3 x 108 CFU of X3589 containing this library, and spleens were harvested 6 days later. All three spleens had S. typhimurium carrying pStSR100 vir-22::TnS and additional smaller plasmids. S. typhimurium from the first spleen had a 7.2-kb plasmid which comigrated with pYA422. The second spleen had S. typhimurium carrying this pYA422-like plasmid or another 8.0-kb plasmid, but not both of the smaller plasmids. S. typhimurium from the third spleen carried a smaller plasmid of 7.0 kb. Plasmid DNA from cultures of spleen homogenates was digested with BamHI and EcoRI and compared with pYA422 and pYA420 DNA cut with the same enzymes.
The 7.2-kb pYA422-like plasmid, designated pYA427, from the first spleen had a restriction digestion profile identical to that of pYA422 (Fig. 1) , indicating that pYA427 must have also carried a BamHI fragment C insert. The 8.0-kb plasmid from the second spleen, designated pYA428, carried BamHI fragment C, with the 0.9-kb BamHI fragment E located immediately to the right of BamHI fragment C (Fig. 1) . The 7.0-kb plasmid from the third spleen, designated pYA429, carried the adjacent regions of BamHI fragments C and D, but not the outermost BamHI sites of these two fragments.
The ability of pYA427, pYA428, and pYA429 to complement vir-22::Tn5 was examined by infecting mice with x3589 which had been retransformed with each of the recombinant plasmids ( Table 2 , part B). Retransformation ensured that complementation by recombinant clones had been originally selected, as opposed to suppressor mutations in pStSR100 vir-22::Tn5. One week after p.o. inoculation with 4 x 108 to 7 x 108 CFU, the total number of splenic CFU in mice infected with X3306 was much greater than that in mice infected with x3589 (2.9 x 105 versus 460 CFU, respectively; P < 0.0005). pYA427, which was identical to pYA422, failed to significantly complement vir- (original orientation); lane D, pYA426 (reversed orientation). Migration of the 28K protein is indicated. P > 0.1). pYA428 was the most efficient complementing plasmid for vir-22::TnS (1.0 x 105 CFU; P > 0.1 compared with X3306, P < 0.005 compared with x3589). pYA429 increased infection of spleens by x3589 (1.9 x 104 CFU; P < 0.025 compared with x3589) but did not restore wild-type virulence (P < 0.05 compared with x3306).
The degree of virulence conferred by each of these plas- (Fig. 3, lanes G to I) . As expected, each of these plasmids encoded a 28K protein.
Reversal of insert DNA of pYA422. After analysis of more detailed restriction maps of pYA422 and the vir-22::TnScomplementing clones, we determined that the insert sequences of the most efficient complementing clones, pYA428 and pYA429, were in the opposite orientation relative to that of the lesser-complementing clones pYA422 and pYA427. Specifically, the insert sequences of pYA428 and pYA429 were oriented so that transcription from the tetracycline resistance gene of pACYC184 (into which sequences were cloned) was from the left (Fig. 1, arrow) , and transcription of the tetracycline resistance gene in pYA422 and pYA427 was from the right (Fig. 1) . The vir-22: :TnS insertion and the gene encoding the 28K protein were located at the extreme left side of the BamHI fragment C shared by all of these plasmids. To determine whether the difference in orientation of insert sequences could have been responsible for the different complementing abilities of the constructs, pYA422 was cleaved with BamHI, which precisely removes the insert sequence, and religated. pYA425 and pYA426, which have the BamHI fragment C insert of pYA422 in the original and opposite orientations, respectively, were isolated ( Fig.  1 ) and tested for their ability to complement vir-22: :TnS. One week after p.o. inoculation of mice with 5 x 108 CFU of X3589(pYA425) or X3589(pYA426), splenic infections of 355 CFU and 1.0 x 106 CFU, respectively, were obtained ( Table  2, Both pYA425 and pYA426 expressed only the 28K protein in E. coli minicells (Fig. 5) were selected during infection of mice. Therefore, the differences in complementation by pYA425 and pYA426 were not due to recombinational events with pStSR100 vir-22::TnS that might have been selected in vivo. Thus, the exact reason for the lack of complementation by pYA422, pYA427, and pYA425 and complementation by pYA426, pYA428, and pYA429 has yet to be determined.
Serum resistance. Although we found no relationship between possession of the 100-kb virulence plasmid and serum resistance of S. typhimurium (14) , others have reported such a relationship (16, 18, 20, 32 (22) . Perhaps one limitation to in vivo selection of chromosomal virulence genes is that a properly avirulent strain must be available for use as a recipient, and such a strain would probably have to be deficient in only the particular gene(s) being cloned.
Three cosmid clones present in isolates of S. typhimurium which were able to infect spleens of mice inoculated p.o.
with cured S. typhimurium X3337 carrying a recombinant library each possessed 22 to 26 kb of insert DNA and a 14-kb common sequence of insert DNA. All of these cosmid clones conferred wild-type levels of virulence on the 100-kb-plasmid-cured S. typhimurium, as determined by infection of spleens of p.o. inoculated mice. Furthermore, pYA403 conferred a wild-type p.o. LD50 ( Table 2 ). The map of our 14-kb common virulence region is very similar to those published by Michiels et al. (27) , who used deletion mutagenesis of the S. typhimurium plasmid; Baird et al. (1), who used transposon insertion mutagenesis of the S. dublin virulence plasmid; and Beninger et al. (4), who used both types of mutagenesis.
To identify smaller sequences of the 100-kb plasmid that conferred virulence, a library with DNA inserts of less than 5 kb in pACYC184 was introduced into plasmid-cured S. typhimurium and fed to mice. A single recombinant clone, pYA422, was isolated from spleens of infected mice that conferred increased but not wild-type levels of splenic infection on virulence plasmid-cured S. typhimurium (Tables  2 and 3 Expression of proteins from the recombinant clones was examined by using E. coli minicell and in vitro transcriptiontranslation analyses. Proteins of 32K, 29K, and 28K (apparent molecular weights) were encoded by pYA403 and pYA420 ( Fig. 2 and 4) , and the 28K protein was encoded by pYA422 ( Fig. 3 and 4) . vir-22::TnS and vir-3::TnS inhibited production of the 28K protein ( Fig. 2 and 3, respectively) .
The fact that vir-22::TnS inhibited virulence conferred by pYA403 and the native virulence plasmid, pStSR100 (Tables  2 and 3 ), suggested that the 28K protein was necessary for virulence. This was indicated further by complementation of vir-22::TnS by pYA428 and pYA429, which encode the 28K protein. pYA422 and pYA427, which are identical and also encode the 28K protein, did not complement vir-22::TnS as well as did pYA428 and pYA429. pYA422 did not complement vir-22::Tn5 because its insert sequence was in the opposite orientation from the tetracycline resistance gene of pACYC184, into which the insert was cloned. This was shown by pYA426, in which the insert sequence of pYA422 was in the reverse orientation and which complemented vir-22: :TnS, and pYA425, which had the insert in the original orientation of pYA422 and did not complement vir-22::TnS. All three plasmids, pYA422, pYA425, and pYA426, expressed the 28K protein in E. coli minicells (Fig. 5) , and pYA426 may have expressed slightly higher amounts of the protein. However, the slightly higher expression does not apparently explain the difference in complementing abilities between these plasmids. Reversal of the insert did not allow expression of new or different proteins between pYA422, pYA425, and pYA426. The reversal of the insert of pYA422 demonstrated that the promoter of the 28K protein gene is encoded within BamHI fragment C. Placement of the 28K protein gene downstream from the tetracycline resistance gene may affect expression of the gene encoding the 28K protein in the genetic background of the virulence plasmid present in x3589, used for complementation experiments. It is also possible that different proteins are expressed in vivo in infected mice but not in minicells or in in vitro transcription-translation. We are currently examining these possibilities. We did eliminate the possibilities that the different complementing abilities were due to plasmid stability differences or recombinational events with the TnS-mutated virulence plasmid. However, until the anomaly of the lack of complementation of vir-22: :Tn5 by certain 28K proteinexpressing plasmids is resolved, a definitive role for the 28K protein in plasmid-mediated virulence cannot be made. The 28K protein by itself is not sufficient to confer a wild-type level of virulence, as evidenced by the lack of wild-type infection of spleens by X3337 carrying pYA422, pYA427, pYA428, or pYA429 (Tables 2 and 3). A major difference in our results and those of others concerning pathogenesis associated with the S. typhimurium virulence plasmid is its role in serum resistance. We have found that curing of the virulence plasmid had no effect on resistance of S. typhimurium to normal human serum, rabbit serum, or guinea pig serum (14 To examine whether serum resistance was conferred by pYA403 and pYA422, E. coli K-12 LE392 and MG1655 carrying each of these plasmids were examined for resistance to normal rabbit serum. Both constructs were as sensitive to serum bactericidal activity as the parental strains (<0.01% survival). It should be emphasized that we could not examine the contributions of these recombinant plasmids to serum resistance in virulence plasmid-cured S. typhimurium because all cured strains in our possession are serum resistant (14) . As we discussed previously (14) , it is possible that our S. typhimurium SR-11 isolate does not depend on any plasmid-encoded factors for serum resistance, as opposed to strains tested by others (16, 18, 32) . The use of the presently described recombinant clones and Tn5 mutations will aid in our ongoing studies of the role of the 100-kb plasmid in S. typhimurium virulence. For example, we are attempting to identify other plasmid-encoded virulence genes by selecting clones that act synergistically with BamHI fragment C to mediate virulence (i.e., infection of spleens after p.o. inoculation).
